Standard Engineering Technology Ltd (SET) has signed a distribution agreement with API Pharma to serve the Middle East region. The collaboration will enhance SET’s reach in pharmaceutical engineering and API solutions, supporting compliance with global GMP standards while addressing the region’s rising demand for advanced pharmaceutical technologies.
Standard Engineering Technology Ltd (SET), a global player in pharmaceutical engineering solutions, has announced a distribution agreement with API Pharma to expand operations in the Middle East. This partnership is expected to accelerate SET’s growth in one of the fastest-emerging pharmaceutical markets, where demand for Active Pharmaceutical Ingredients (APIs) and advanced process equipment is rising.
SET brings decades of expertise in designing and delivering GMP-compliant systems for API manufacturing, including solutions for containment, solvent handling, and batch integrity. By joining forces with API Pharma, SET aims to provide a seamless supply chain and localized support to pharmaceutical manufacturers in the region.
The agreement reflects a broader industry trend of strengthening regional partnerships to meet the growing need for high-potency APIs, compliance-driven processes, and advanced engineering technologies.
Key Highlights
-
Partnership: SET enters distribution agreement with API Pharma
-
Region: Middle East
-
Focus: Pharmaceutical engineering, API manufacturing solutions
-
Strengths of SET:
-
Expertise in GMP-compliant equipment
-
Strong footprint in API sector
-
Integrated engineering solutions for safety and repeatability
-
Objective: Expand market presence, support regional pharmaceutical growth, and deliver advanced process technologies
Sources: Standard Engineering Technology official site, LinkedIn market insights, API Conference materials